Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Brandon W. Hanson
Observed name:
Brandon Hanson
Institution:
University of Nebraska Medical Center
Observed institution:
University of Nebraska Medical Center
ORCID:
0009-0007-0740-1201
Observed ORCID:
0009-0007-0740-1201
OpenAlex ID:
A5011794164
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
2022
·
Suyash Deodhar
, Brady Sillman
, et al.
·
Nature Communications
·
53
PDF
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression
2022
·
Srijanee Das
, Weimin Wang
, et al.
·
Science Advances
·
22
CCR5-ligand decorated rilpivirine lipid-based nanoparticles for sustained antiretroviral responses
2025
·
Milankumar Patel
, Sudipta Panja
, et al.
·
Nature Communications
·
10
PDF
A scalable ultra-long-acting tenofovir phosphonate prodrug sustains HBV suppression
2025
·
Samiksha S. Raut
, Srijanee Das
, et al.
·
Science Advances
·
6
An ultra-long-acting dimeric bictegravir prodrug defined by a short pharmacokinetic tail
2026
·
Mohammad Ullah Nayan
, Brady Sillman
, et al.
·
Nature Communications
·
4
An Ultra-Long-Acting Buprenorphine Prodrug Ion-Pair for Opioid Use Disorder
2026
·
Benson Edagwa
, Ashrafi Sultana
, et al.
·
Research Square
A Long-Acting Farnesoid X Receptor (FXR) Agonist Prevents Fibrosis
2026
·
Ashrafi Sultana
, Grace Bybee
, et al.
·
Biomolecules
Show more works
View as search
Works count:
7
Citation count:
95
H-index:
4
I10-index:
3
Year
Topic
Type